Adebayo Alonge

Shí Wikipedia, njikotá édémédé nke onyobulạ
Adebayo Alonge
Mmádu
ụdịekerenwoke Dezie
Ọrụ ọ na-arụinventor, Onyeisi azụmahịa, ọkà mmụta sayensị kọmputa Dezie
ebe agụmakwụkwọPan-Atlantic University Dezie

   ADEDAYO ADEGBOYE bụ Onye Naijiria na-ahụ maka ọgwụ, onye na-emepụta ihe, onye ọchụnta ego teknụzụ miri emi, na onye ọkachamara na mmepe ahịa. Ọ bụ onye mmeri nke 2019 Hello Tomorrow Global Deeptech Challenge, nke a maara dị ka BNP Paribas Group Deep Tech Award, maka ịmepụta nano-scanner aka nke na-achọpụta ọgwụ adịgboroja.

Ọ bụzi onye isi oche na onye guzobere [1] Inc. - ụlọ ọrụ na-amalite teknụzụ miri emi na United States. [2]

Mmụta[dezie | dezie ebe o si]

Adebayo Alonge gara King's College, Lagos, n'etiti afọ 1996 na 2002. Ọ gụrụ ọgwụ na Mahadum nke Ibadan, ma gụsịrị akwụkwọ na klas mbụ na 2008. [3]    nwere nzere Master of Business Administration (nke na-elekwasị anya na Strategy na Finance) site na Lagos Business School - Pan-Atlantic University ma nwee Master of Advanced Management site na Yale University - Yale School of Management . [1] [4] bụ onye gụsịrị akwụkwọ na Hitotsubashi University Graduate School of International Corporate Strategy, ma na-amụ Master of Public Administration (Mason Program) na Harvard Kennedy School - Mahadum Harvard. [1]

Ọrụ[dezie | dezie ebe o si]

Adebayo Alonge jere ozi na ikike ndị a dị ka Onye nnọchi anya ahụike nke Sanofi n'etiti Nọvemba 2009 na Septemba 2010, yana Onye na-ahụ maka ọgwụ nkwekọrịta na Global HIV / AIDS Initiative. Ọ rụrụ ọrụ dị ka Onye nnọchi anya ahụike Nkume Roche (nke bụ Swiss Pharma Nigeria ugbu a) site na Septemba 2010 ruo Ọktoba 2012, yana dị ka onye na-ahụ maka Mmepe Ahịa [5] (Pharma Ingredients) nke BASF, ụlọ ọrụ kemịkal Germany ebe ọ rụrụ ọrụ site na Julaị 2013 ruo Ọkọba 2013. Ọ rụrụ ọrụ dị ka onye mmepe ahịa na BASF West Africa site n'August 2014 ruo August 2015 nakwa, ọ bụkwa Onye nduzi mmepe azụmaahịa na "Lusoy Investments Limited" n'etiti Eprel 2012 ruo Ọktoba 2017 ma n'oge Nọvemba 2015 ruo Ọkọba 2017 ọ rụrụ ọrụ dị hi Onye ndụmọdụ na The Boston Consulting Group.

N'afọ 2016, Alonge guzobere RxAll Inc. na-ezube igbochi ndị ọrịa ịṅụ Ọgwụ adịgboroja ma nye ha ụzọ ha ga-esi kwado ọgwụ ha. RxAll. [6] nwere ndị otu atọ; Alonge dị ka Onye isi ọrụ, Amy Kao dị ka onye nduzi ahịa, na Wei Liu dị ka onye ndú teknụzụ.

Onyinye, nsọpụrụ na mmata[dezie | dezie ebe o si]

Adebayo Alonge has received the Adekunle Ajasin Award for Academic Excellence in 2008, the Mandela Washington Fellowship from[7] the United States Department of State for outstanding contributions to business and entrepreneurship in Africa in 2014, and the Global Social Venture Award from InnovateHealth, Yale University in 2016. Adebayo Alonge won the 2018 China Award for Best DeepTech Platform in the World, he also got a €100,000 prize for a DeepTech award. Some of the other things he won were the Grand Winner & Digital Health Winner in 2019, the Hello Tomorrow Global Challenge 2019, the Young Innovator – YouWin!, the Regional finalist, Hult Prize Global Case Competition and awards in person from Barack Obama (ex-president of the United States) and Justin Trudeau (prime minister of Canada).

Njikọ mpụga[dezie | dezie ebe o si]

Hụkwa[dezie | dezie ebe o si]

  • RxAll

Ihe odide[dezie | dezie ebe o si]

  1. "Fake pharmaceutical industry thrives in West Africa", BBC News, 2020-07-13. Retrieved on 2020-08-07. (in en-gb)
  2. RxAll, Founded by Adebayo Alonge '16, Named Best Early-Stage Startup in Hello Tomorrow Global Challenge (en). Yale School of Management (2019-03-21). Retrieved on 2020-01-20.
  3. Five questions to .... Adebayo Alonge – IFPMA. www.ifpma.org. Retrieved on 2020-01-20.
  4. Xiong (April 6, 2018). New startup targets fake drugs (en). yaledailynews.com. Retrieved on 2020-08-07.
  5. Meet Adebayo Alonge, the Nigeran pharmacist who beat Tech startups from 119 countries to win the grand prize of €100,000. www.pulse.ng (25 March 2019). Retrieved on 2020-01-20.
  6. Adebayo Alonge. summit.techsauce.co. Retrieved on 2020-01-20.
  7. Ekwealor (2019-03-22). Nigerian deep tech startup, RxAll is looking to squash the $30 billion global fake drug industry (en-US). Techpoint.Africa. Retrieved on 2020-01-20.